What is Esperion Therapeutics's net margin?

Esperion Therapeutics (ESPR) reported net margin of -34.8% in Q3 2025.

How has Esperion Therapeutics's net margin changed year-over-year?

Esperion Therapeutics's net margin decreased by 18.6% year-over-year, from -29.4% to -34.8%.

What is the long-term trend for Esperion Therapeutics's net margin?

Over 4 years (2020 to 2024), Esperion Therapeutics's net margin has grown at a -29.5% compound annual growth rate (CAGR), from -63.1% to -15.6%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Esperion Therapeutics ESPR Net margin

Net margin at other companies

AmgenAMGN

21%+3.6pp

Regeneron PharmaceuticalsREGN

29.6%-2.3pp

NewAmsterdam Pharma CompanyNAMS

-942.8%-3,477pp

Lexicon PharmaceuticalsLXRX

-37.5%-18.1pp

Eton Pharmaceuticals, Inc.ETON

-9.5%-2.7pp

Zevra Therapeutics, Inc.ZVRA

101.6%+60.1pp

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

net income/total revenue=-34.8%

Based on trailing twelve months.

The official record: Esperion Therapeutics’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's net margin?: Esperion Therapeutics (ESPR) reported net margin of -34.8% in Q3 2025.
How has Esperion Therapeutics's net margin changed year-over-year?: Esperion Therapeutics's net margin decreased by 18.6% year-over-year, from -29.4% to -34.8%.
What is the long-term trend for Esperion Therapeutics's net margin?: Over 4 years (2020 to 2024), Esperion Therapeutics's net margin has grown at a -29.5% compound annual growth rate (CAGR), from -63.1% to -15.6%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.